MAY 01, 2018 12:00 PM PDT

CNS Tumor Cells Destroyed by Zika Virus

WRITTEN BY: Mauri Brueggeman

Central Nervous System (CNS) tumors have historically be categorized though histopathology (a microscope-based approach).  Tumors are surgically removed and then biopsied to determine a diagnosis, prognosis, and treatment determinations.  With advances in molecular and genetic profiling of tumors, researchers and providers found that the combination of CNS tumor biodiversity and their unique molecular markers really define brain tumor types.  The World Health Organization (WHO) reclassified CNS tumors in 2016 based on this information.  There are additional recognized entities based on variants and patterns in Glioblastomas and Ganglion Cell tumors for example.  An “integrated diagnosis”, based on the new edition of WHO brain tumor classifications will be more precise and include: histological diagnosis, WHO histological grade, and molecular information.

The changes in the WHO classification have helped provide guidance on molecular markers that can be targets of new immunotherapies.  It helps differentiate the cellular makeup of particular tumors that could not be determined prior. 

On April 26, 2018, a Brazilian study was published in the journal Cancer Research utilizing the Zika Virus to kill CNS tumor cells.  The group focused their work on embryonal CNS tumors because these are found to be aggressive and reveal themselves close to birth or in early adolescence.  These are fast growing tumors that cause damage as the CNS is developing in a child.  The researchers focused initially on Zika because it infects and destroys neural stem cells in the fetus and prevents the formation of new neurons.  While not fully understood, it is suspected that Zika targets the neural stem cell surface marker AXL.  They wondered if the virus could attack tumor stem cells in the CNS, given its modus operandi in healthy tissue.

They examined the effects of Zika on three human tumor cell lines derived from medulloblastoma and atypical teratoid/rhabdoid tumors (AT/RT).  These cancers are caused by stem cell DNA aberrations and affect neural progenitor cells during development and cellular maturation processes.  The group also infected other tumor cell line types from breast, prostate, and colorectal cancers as a comparative to neural tissue tumor effects.

Results showed that even small amounts of Zika virus were enough to infect CNS tumor cells.  In far fewer numbers, prostate cells were infected.  No amount of Zika used in the experiment was enough to induce infection of breast or colorectal cancer cells. 

The group also examined the comparative capacity of Zika to infect CNS tumor cells and healthy neural stem cells.  Surprisingly, the CNS tumor cells were more susceptible to destruction by Zika than the healthy stem cells.  The AT/RT tumor cell line was: 1. most sensitive to infection and, 2. the closest in molecular resemblance to healthy neural stem cells.  The group also found that upon initial examination, Zika can also infect and kill other kinds of CNS tumor types including glioblastoma.

More research must be done to continue developing the potential of using Zika to destroy CNS tumors while not damaging healthy brain tissue in vivo; we have seen the consequences of this virus painfully manifested in children born in the very recent past, so it is prudent to consider how to meaningfully use Zika in a controlled way.

Sources: Cancer Research, Sao Paulo Research Foundation, National Brain Tumor Society,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
MAR 22, 2020
Cancer
MAR 22, 2020
What is "Shotgun ion mobility mass spectrometry sequencing"?
Research published recently in Nature Communications highlights a new method of mapping an essential family of polysacch ...
MAR 28, 2020
Cancer
MAR 28, 2020
The Not So Minor Genetic Players in Head and Neck Cancers
Head and neck squamous cell carcinomas (HNSCC) are among the most prevalent cancers among smokers, linked to alcohol con ...
APR 11, 2020
Cancer
APR 11, 2020
The Mice Make the Difference in CAR-T Studies
It is quite common in cancer therapies to see a drug or treatment that has been around for decades. New drugs are hard t ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Drug Targets Hard To Treat Uterine Cancer
A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The dru ...
MAY 06, 2020
Cancer
MAY 06, 2020
Olanzapine useful for cancer patients managing nausea unrelated to chemo
A study published last week in JAMA Oncology reports that a generic drug called Olanzapine could be useful for cancer pa ...
MAY 10, 2020
Drug Discovery & Development
MAY 10, 2020
Antiviral Drug Treats Naso-Pharyngeal Cancer
Scientists at Hong Kong Baptist University (HKBU) developed a novel anti-Epstein-Barr virus (EBV) drug that can shrink t ...
Loading Comments...